The enhanced uPA signaling induced cell proliferation and inhibited apoptosis of human pulmonary artery smooth muscle cells via uPAR-sparing pathways, leading to proliferative vasculopathy in SSc [51,52]. The gene discussed is PLAU; the disease is vascular disorder.